- Home
- SYK
as 11-20-2024 4:00pm EST
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
| Founded: | 1941 | Country: | United States |
| Employees: | N/A | City: | PORTAGE |
| Market Cap: | 146.1B | IPO Year: | N/A |
| Target Price: | $395.42 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 19 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 9.33 | EPS Growth: | 38.37 |
| 52 Week Low/High: | $285.79 - $398.20 | Next Earning Date: | 10-29-2024 |
| Revenue: | $21,974,000,000 | Revenue Growth: | 10.51% |
| Revenue Growth (this year): | 11.34% | Revenue Growth (next year): | 8.11% |
Stock Insider Trading Activity of Stryker Corporation (SYK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | SYK | Director10% Owner | Nov 5 '24 | Sell | $366.98 | 230,000 | $84,494,989.68 | 3,307,354 | |
| Fink M Kathryn | SYK | VP, Chief HR Officer | Sep 13 '24 | Sell | $367.13 | 9,468 | $3,480,956.20 | 10,042 | |
| Menon Viju | SYK | Group President | Aug 27 '24 | Sell | $355.00 | 600 | $213,000.00 | 9,069 |
Latest Stryker Corporation News
SYK Breaking Stock News: Dive into SYK Ticker-Specific Updates for Smart Investing
Zacks
20 hours ago
Stryker Stock May Gain From Oculan Lighting Platform's Launch
FX Empire
a day ago
Stryker Bringing in Big Money
PR Newswire
2 days ago
Stryker unveils Oculan Lighting Platform to enhance surgical visualization and illumination
Zacks
6 days ago
SYK Stock Rises Following the Launch of Next Generation SurgiCount+
PR Newswire
7 days ago
Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment
Morningstar Research
8 days ago
Analyst Report: Stryker Corporation
Zacks
10 days ago
PBH vs. SYK: Which Stock Is the Better Value Option?
Simply Wall St.
10 days ago
Stryker Insiders Sell US$261m Of Stock, Possibly Signalling Caution
Compare SYK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SYK Stryker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.